ST002319 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with tamoxifen and trastuzumab | ||||
Limit by pathway class: | Minimum # of metabolites per pathway: |
ST002319 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with tamoxifen and trastuzumab | ||||
Limit by pathway class: | Minimum # of metabolites per pathway: |
![]() |